5 Most Promising Long-Term Stocks According to Analysts

Page 5 of 5

1. Relay Therapeutics, Inc. (NASDAQ:RLAY)

Average Analyst Share Price Target Percentage Upside: 98.23%

Average Share Price Target: $22.40

Relay Therapeutics, Inc. (NASDAQ:RLAY) is a biotechnology company developing treatments for several different tumors. It is also the only firm on our list that has a collaboration with billionaire D. E. Shaw’s research firm to develop drugs.

As of Q3 2023 end, 27 out of the 910 hedge funds tracked by Insider Monkey had invested in Relay Therapeutics, Inc. (NASDAQ:RLAY). Eli Casdin’s Casdin Capital was the biggest stakeholder through its $58.2 million investment.

Follow Relay Therapeutics Inc. (NASDAQ:RLAY)

Disclosure: None. You can also take a look at 25 Cities With The Hottest Guys In The World and 12 Best Stocks to Buy for an 18 Year Old.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5